+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pain Management Devices Market Size, Share & Trends Analysis Report By Product (RFA, Neurostimulation), By Application (Neuropathic Pain, Facial & Migraine, MSDs, Trauma, Cancer), And Segment Forecasts, 2019 - 2026

  • ID: 4778242
  • Report
  • September 2019
  • Region: Global
  • 120 pages
  • Grand View Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • B Braun Melsungen AG
  • Baxter International
  • Codman and Shurtleff
  • DJO Global LLC
  • Medtronic Plc.
  • Pfizer
  • MORE
The global pain management devices market size is expected to reach USD 9.3 billion by 2026 registering a CAGR of 7.6%, according to this study. Rising prevalence of diabetes, coupled with increasing geriatric population base across the globe, is the major factor augmenting the growth of this market. Preference for pain management devices over oral drugs and surgical interventions is also likely to be a high impact rendering driver for the market over the forecast period.

The global market is expected to witness strong growth as a result of various technological advancements in this field. These advancements include the advent of products such as electrode-based wearable automatic transcutaneous electrical nerve stimulators, which provide peripheral pain management in a 60-minute run cycle.

Neurostimulation devices are more efficient than traditional methods as they show a sustained reduction in pain. Additionally, traditional therapy involves intake of medicines that could result in many adverse effects. Such equipment is widely used to manage neuropathic pain as spinal cord stimulators yield the best results. Moreover, these devices offer a customized level of stimulation depending on the activities undertaken by the patient in a day.

North America was the largest regional market in 2018 and held around half of the global revenue owing to the increased number of people affiliated with pain and thereby requiring management devices. The region is expected to maintain its dominance throughout the forecast years on account of presence of sophisticated healthcare infrastructure and rising adoption of advanced equipment by healthcare professionals and patients over conventional treatment therapies.

Further key findings from the study suggest:
  • By product, neurostimulation led the global market in 2018, accounting for a revenue share of more than 60.0%. These devices have higher preference over traditional technologies due to their higher efficiency in terms of providing relief for a longer duration
  • The radiofrequency ablation segment is expected to witness the highest CAGR from 2019 to 2026. Rising usage of these devices to cure cancer is the major factor driving their adoption. Long-term relief from cancer pain is also a high impact rendering driver for this segment
  • Key companies in the global pain management devices market include B Braun Melsungen AG.; Baxter International, Inc.; Boston Scientific Corp.; Codman and Shurtleff; DJO Global LLC; Pfizer, Inc.; Medtronic Plc; Smiths Medical; Stryker Corp.; and St. Jude Medica.

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • B Braun Melsungen AG
  • Baxter International
  • Codman and Shurtleff
  • DJO Global LLC
  • Medtronic Plc.
  • Pfizer
  • MORE
Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 Internal database
1.3.3 Secondary sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.3.5.1 Data for primary interviews in North America
1.3.5.2 Data for primary interviews in Europe
1.3.5.3 Data for primary interviews in Asia Pacific
1.3.5.4 Data for primary interviews in Middle East and Africa
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Report Objectives

Chapter 2 Executive Summary
2.1 Market Outlook
2.1.1 Pain Management Devices market Outlook, 2014-2026 (USD Million)
2.2 Segment Outlook
2.3 Competitive Outlook
2.4 Pain Management Devices Market Summary, 2018

Chapter 3 Pain Management Devices Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market analysis
3.1.2 Ancillary market Analysis
3.2 Penetration & Growth Prospect Mapping
3.3 Technology Timeline Overview
3.4 Pricing trend analysis
3.4.1 Technology timeline pain management devices changing technology & adoption
3.5 Regulatory Framework
3.5.1 List of regulatory bodies
3.6 Pain Management Devices Market Dynamics
3.6.1 Market driver analysis
3.6.1.1 Rising prevalence of diabetes coupled with rising geriatric population base globally
3.6.1.2 Rising incidence of cancer
3.6.1.3 Rising neuropathic pain disorders
3.6.1.4 Ineffectiveness of oral drugs and lack of preference for surgical intervention
3.6.1.5 Favorable reimbursement policies
3.6.1.6 Rising demand for reduced hospital stay
3.6.1.7 Technological advancements
3.6.2 Market restraint analysis
3.6.2.1 Side effects associated with these devices
3.7 Pain Management Devices Market Analysis Tools: Porters
3.7.1 Supplier Power
3.7.2 Buyer Power
3.7.3 Threat Of Substitutes
3.7.4 Threat Of New Entrants
3.7.5 Competitive Rivalary
3.8 PESTEL Analysis
3.8.1 Political Landscape
3.8.2 Economic Landscape
3.8.3 Social Landscape
3.8.4 Technology Landscape
3.8.5 Environmental Landscape
3.8.6 Legal Landscape
3.9 Major Deals & Strategic Alliances Analysis
3.9.1 Mergers & Acquisitions
3.9.2 product launch
3.9.3 Expansion
3.9.4 Partnership & Collaborations
3.9.5 Market Entry Strategies

Chapter 4 Pain Management Devices Market: Competitive Analysis
4.1 Market Participation Categorization
4.2 Public Companies
4.2.1 Company market position analysis
4.2.2 Competitive Dashboard Analysis
4.2.2.1 Market Differentiators
4.2.3 Company Market Share
4.2.4 Competitive Dashboard Analysis
4.3 Private Companies
4.3.1 List of key emerging companies

Chapter 5 Pain Management Devices Market: Product Estimates & Trend Analysis
5.1 Product Market Share Analysis, 2018 & 2026
5.2 Product Dashboard
5.2.1 Electrical stimulators
5.2.1.1 Electrical stimulators market estimates and forecasts, 2014-2026 (USD Million)
5.2.1.2 TENS (Transcutaneous Electrical Nerve Stimulators)
5.2.1.2.1 TENS (Transcutaneous Electrical Nerve Stimulators) market estimates and forecasts, 2014-2026 (USD Million)
5.2.1.3 Other electrical stimulators
5.2.1.3.1 Other electrical stimulators market estimates and forecasts, 2014-2026 (USD Million)
5.2.2 Radiofrequency ablation
5.2.2.1 Radiofrequency ablation market estimates and forecasts, 2014-2026 (USD Million)
5.2.3 Analgesic infusion pumps
5.2.3.1 Analgesic infusion pumps market estimates and forecasts, 2014-2026 (USD Million)
5.2.3.2 Intrathecal infusion pumps
5.2.3.2.1 Intrathecal infusion pumps market estimates and forecasts, 2014-2026 (USD Million)
5.2.3.3 External infusion pumps
5.2.3.3.1 External infusion pumps market estimates and forecasts, 2014-2026 (USD Million)
5.2.4 Neurostimulation
5.2.4.1 Neurostimulation market estimates and forecasts, 2014-2026 (USD Million)
5.2.4.2 Spinal cord stimulators
5.2.4.2.1 Spinal cord stimulators market estimates and forecasts, 2014-2026 (USD Million)
5.2.4.3 Deep brain stimulators
5.2.4.3.1 Deep brain stimulators market estimates and forecasts, 2014-2026 (USD Million)
5.2.4.4 Sacral neurostimulators
5.2.4.4.1 Sacral neurostimulators market estimates and forecasts, 2014-2026 (USD Million)
5.2.4.5 Others
5.2.4.5.1 Others market estimates and forecasts, 2014-2026 (USD Million)

Chapter 6 Pain Management Devices Market: Application Estimates & Trend Analysis
6.1 Application Market Share Analysis, 2018 & 2026
6.2 Application Dashboard
6.3 Cancer
6.3.1 Cancer market estimates and forecasts, 2014-2026 (USD Million)
6.4 Neuropathic pain
6.4.1 neuropathic pain market estimates and forecasts, 2014-2026 (USD Million)
6.5 Facial & migraine
6.5.1 Facial & migraine market estimates and forecasts, 2014-2026 (USD Million)
6.6 Musculoskeletal disorder
6.6.1 Musculoskeletal disorder market estimates and forecasts, 2014-2026 (USD Million)
6.7 Trauma
6.7.1 Trauma market estimates and forecasts, 2014-2026 (USD Million)

Chapter 7 Pain Management Devices Market: Regional Estimates & Trend Analysis, By, Product, Application
7.1 Regional Market Snapshot
7.2 Market Share Analysis by Country, 2018
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 MEA
7.3 North America
7.3.1 North America Pain Management Devices market estimates and forecasts, 2014-2026 (USD Million)
7.3.2 U.S.
7.3.2.1 U.S. Pain Management Devices market estimates and forecasts, 2014-2026(USD Million)
7.3.3 Canada
7.3.3.1 Canada Pain Management Devices market estimates and forecasts, 2014-2026(USD Million)
7.4 Europe
7.4.1 Europe Pain Management Devices MARKET estimates and forecasts, 2014-2026 (USD Million)
7.4.2 U.K.
7.4.2.1 U.K. Pain Management Devices market estimates and forecasts, 2014-2026(USD Million)
7.4.3 Germany
7.4.3.1 Germany Pain Management Devices market estimates and forecasts, 2014-2026 (USD Million)
7.4.4 France
7.4.4.1 France Pain Management Devices market estimates and forecasts, 2014-2026 (USD Million)
7.4.5 Italy
7.4.5.1 Italy Pain Management Devices market estimates and forecasts, 2014-2026 (USD Million)
7.4.6 Spain
7.4.6.1 Spain Pain Management Devices market estimates and forecasts, 2014-2026 (USD Million)
7.4.7 Russia
7.4.7.1 Russia Pain Management Devices market estimates and forecasts, 2014-2026 (USD Million)
7.5 Asia Pacific
7.5.1 Asia Pacific Pain Management Devices market estimates and forecasts, 2014-2026 (USD Million)
7.5.2 Japan
7.5.2.1 Japan Pain Management Devices market estimates and forecasts, 2014-2026 (USD Million)
7.5.3 China
7.5.3.1 China Pain Management Devices market estimates and forecasts, 2014-2026 (USD Million)
7.5.4 India
7.5.4.1 India Pain Management Devices market estimates and forecasts, 2014-2026 (USD Million)
7.6 Latin America
7.6.1 Latin America Pain Management Devices market estimates and forecasts, 2014-2026 (USD Million)
7.6.2 Mexico
7.6.2.1 Mexico Pain Management Devices market estimates and forecasts, 2014-2026 (USD Million)
7.6.3 Brazil
7.6.3.1 Brazil Pain Management Devices market estimates and forecasts, 2014-2026 (USD Million)
7.7 MEA
7.7.1 MEA Pain Management Devices market estimates and forecasts, 2014-2026 (USD Million)
7.7.2 South Africa
7.7.2.1 South Africa Pain Management Devices market estimates and forecasts, 2014-2026 (USD Million)
7.7.3 Saudi Arabia
7.7.3.1 Saudi Arabia Pain Management Devices market estimates and forecasts, 2014-2026 (USD Million)

Chapter 8 Company Profiles
8.1 B Braun Melsungen AG
8.1.1 Company overview
8.1.2 Financial performance
8.1.3 Product benchmarking
8.1.4 Strategic initiatives
8.2 Baxter International
8.2.1 Company overview
8.2.2 Product benchmarking
8.2.3 Strategic initiatives
8.3 Boston Scientific Corporation
8.3.1 Company overview
8.3.2 Financial Performance
8.3.3 Product benchmarking
8.3.4 Strategic initiatives
8.4 Codman and Shurtleff
8.4.1 Company overview
8.4.2 Financial Performance
8.4.3 Product benchmarking
8.4.4 Strategic initiatives
8.5 DJO Global LLC
8.5.1 Company overview
8.5.2 Product benchmarking
8.5.3 Strategic initiatives
8.6 Pfizer
8.6.1 Company overview
8.6.2 Financial Performance
8.6.3 Product benchmarking
8.6.4 Strategic initiatives
8.7 Medtronic Plc.
8.7.1 Company overview
8.7.2 Product benchmarking
8.8 Smiths Medical
8.8.1 Company overview
8.8.2 Financial Performance
8.8.3 Product benchmarking
8.8.4 Strategic initiatives
8.9 St. Jude Medicals
8.9.1 Company overview
8.9.2 Financial performance
8.9.3 Product benchmarking
8.9.4 Strategic initiatives
8.10 Stryker Corporation
8.10.1 Company overview
8.10.2 Financial performance
8.10.3 Product benchmarking
8.10.4 Strategic initiatives


*Full List of Tables and Figures Available on Enquiry.
Note: Product cover images may vary from those shown
3 of 3
  • B Braun Melsungen AG
  • Baxter International
  • Boston Scientific Corporation
  • Codman and Shurtleff
  • DJO Global LLC
  • Pfizer
  • Medtronic Plc.
  • Smiths Medical
  • St. Jude Medicals
  • Stryker Corporation
Note: Product cover images may vary from those shown
Adroll
adroll